

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA unwinding involved in DNA replication (GO:0006268) | 5.01996396 |
| 2 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.42233735 |
| 3 | regulation of translational fidelity (GO:0006450) | 4.41451834 |
| 4 | protein localization to kinetochore (GO:0034501) | 3.99361757 |
| 5 | nuclear pore organization (GO:0006999) | 3.95242865 |
| 6 | nuclear pore complex assembly (GO:0051292) | 3.89650614 |
| 7 | pre-miRNA processing (GO:0031054) | 3.81441765 |
| 8 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.74284947 |
| 9 | heterochromatin organization (GO:0070828) | 3.73339741 |
| 10 | protein localization to endosome (GO:0036010) | 3.72573229 |
| 11 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.68473074 |
| 12 | peptidyl-lysine dimethylation (GO:0018027) | 3.63377167 |
| 13 | regulation of translational termination (GO:0006449) | 3.61076521 |
| 14 | mitotic nuclear envelope disassembly (GO:0007077) | 3.57629149 |
| 15 | pentose-phosphate shunt (GO:0006098) | 3.57596987 |
| 16 | protein retention in ER lumen (GO:0006621) | 3.47513483 |
| 17 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.47395090 |
| 18 | dosage compensation (GO:0007549) | 3.45293953 |
| 19 | DNA duplex unwinding (GO:0032508) | 3.42993391 |
| 20 | negative regulation of RNA splicing (GO:0033119) | 3.40348244 |
| 21 | membrane disassembly (GO:0030397) | 3.40066776 |
| 22 | nuclear envelope disassembly (GO:0051081) | 3.40066776 |
| 23 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.38977668 |
| 24 | DNA geometric change (GO:0032392) | 3.38509500 |
| 25 | pinocytosis (GO:0006907) | 3.37839391 |
| 26 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.34732833 |
| 27 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.34732833 |
| 28 | mRNA stabilization (GO:0048255) | 3.33434254 |
| 29 | RNA stabilization (GO:0043489) | 3.33434254 |
| 30 | protein localization to chromosome, centromeric region (GO:0071459) | 3.31881854 |
| 31 | proline biosynthetic process (GO:0006561) | 3.30512675 |
| 32 | maternal placenta development (GO:0001893) | 3.27538686 |
| 33 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.22254965 |
| 34 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.21783307 |
| 35 | positive regulation of histone deacetylation (GO:0031065) | 3.21504411 |
| 36 | IMP biosynthetic process (GO:0006188) | 3.19688809 |
| 37 | barbed-end actin filament capping (GO:0051016) | 3.19134512 |
| 38 | regulation of early endosome to late endosome transport (GO:2000641) | 3.16981715 |
| 39 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.16394410 |
| 40 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.16394410 |
| 41 | chromatin assembly (GO:0031497) | 3.15127049 |
| 42 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.15053198 |
| 43 | Golgi transport vesicle coating (GO:0048200) | 3.14445753 |
| 44 | COPI coating of Golgi vesicle (GO:0048205) | 3.14445753 |
| 45 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.12346452 |
| 46 | negative regulation of histone methylation (GO:0031061) | 3.11599907 |
| 47 | glucose catabolic process (GO:0006007) | 3.11332065 |
| 48 | regulation of sister chromatid cohesion (GO:0007063) | 3.08357389 |
| 49 | mitotic chromosome condensation (GO:0007076) | 3.07785490 |
| 50 | NADPH regeneration (GO:0006740) | 3.06764371 |
| 51 | glucocorticoid receptor signaling pathway (GO:0042921) | 3.06705430 |
| 52 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.04497470 |
| 53 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.04093946 |
| 54 | translesion synthesis (GO:0019985) | 3.03942266 |
| 55 | activation of Rac GTPase activity (GO:0032863) | 3.02698827 |
| 56 | sister chromatid segregation (GO:0000819) | 3.02053601 |
| 57 | embryonic process involved in female pregnancy (GO:0060136) | 2.97265264 |
| 58 | negative regulation of mRNA processing (GO:0050686) | 2.96444350 |
| 59 | cell-substrate adherens junction assembly (GO:0007045) | 2.94657955 |
| 60 | focal adhesion assembly (GO:0048041) | 2.94657955 |
| 61 | mitotic sister chromatid cohesion (GO:0007064) | 2.93715348 |
| 62 | stress fiber assembly (GO:0043149) | 2.92556448 |
| 63 | negative regulation of cell size (GO:0045792) | 2.92552632 |
| 64 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.91768579 |
| 65 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.90958818 |
| 66 | modulation by symbiont of host cellular process (GO:0044068) | 2.90782621 |
| 67 | negative regulation of mRNA metabolic process (GO:1903312) | 2.90257196 |
| 68 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.89903425 |
| 69 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.87386296 |
| 70 | nuclear envelope organization (GO:0006998) | 2.86598862 |
| 71 | regulation of histone H3-K9 methylation (GO:0051570) | 2.83075554 |
| 72 | NLS-bearing protein import into nucleus (GO:0006607) | 2.81448321 |
| 73 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.79495040 |
| 74 | glucose 6-phosphate metabolic process (GO:0051156) | 2.79326498 |
| 75 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.79295979 |
| 76 | IMP metabolic process (GO:0046040) | 2.76980516 |
| 77 | histone H2A monoubiquitination (GO:0035518) | 2.76334509 |
| 78 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.74781347 |
| 79 | NIK/NF-kappaB signaling (GO:0038061) | 2.74601168 |
| 80 | cell-substrate junction assembly (GO:0007044) | 2.73760722 |
| 81 | regulation of protein heterodimerization activity (GO:0043497) | 2.73597886 |
| 82 | DNA strand elongation (GO:0022616) | 2.73225320 |
| 83 | regulation of RNA export from nucleus (GO:0046831) | 2.72052879 |
| 84 | establishment of apical/basal cell polarity (GO:0035089) | 2.71877459 |
| 85 | paraxial mesoderm development (GO:0048339) | 2.69146870 |
| 86 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.69021144 |
| 87 | regulation of gene silencing by miRNA (GO:0060964) | 2.69021144 |
| 88 | regulation of gene silencing by RNA (GO:0060966) | 2.69021144 |
| 89 | T cell apoptotic process (GO:0070231) | 2.66587243 |
| 90 | modulation by virus of host process (GO:0019054) | 2.66464754 |
| 91 | pore complex assembly (GO:0046931) | 2.65284388 |
| 92 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.65211107 |
| 93 | viral transcription (GO:0019083) | 2.65138235 |
| 94 | cellular response to virus (GO:0098586) | 2.64367005 |
| 95 | response to laminar fluid shear stress (GO:0034616) | 2.64072005 |
| 96 | regulation of hippo signaling (GO:0035330) | 2.63582702 |
| 97 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.62065083 |
| 98 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.61522807 |
| 99 | mitotic sister chromatid segregation (GO:0000070) | 2.61157295 |
| 100 | tetrahydrofolate metabolic process (GO:0046653) | 2.60723543 |
| 101 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.60459491 |
| 102 | regulation of spindle organization (GO:0090224) | 2.60257572 |
| 103 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.59209601 |
| 104 | apoptotic process involved in morphogenesis (GO:0060561) | 2.58790646 |
| 105 | regulation of defense response to virus by virus (GO:0050690) | 2.58574161 |
| 106 | translational termination (GO:0006415) | 2.57982169 |
| 107 | positive regulation of nuclease activity (GO:0032075) | 2.57851005 |
| 108 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.57112077 |
| 109 | formation of translation preinitiation complex (GO:0001731) | 2.55371987 |
| 110 | regulation of mRNA stability (GO:0043488) | 2.55317117 |
| 111 | mitotic G1/S transition checkpoint (GO:0044819) | 2.53851566 |
| 112 | DNA replication initiation (GO:0006270) | 2.53669226 |
| 113 | basement membrane organization (GO:0071711) | 2.53405390 |
| 114 | positive regulation by symbiont of host defense response (GO:0052509) | 2.53338068 |
| 115 | modulation by symbiont of host defense response (GO:0052031) | 2.53338068 |
| 116 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.53338068 |
| 117 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.53338068 |
| 118 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.53338068 |
| 119 | modulation by symbiont of host immune response (GO:0052553) | 2.53338068 |
| 120 | embryonic foregut morphogenesis (GO:0048617) | 2.53145638 |
| 121 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.52636224 |
| 122 | DNA conformation change (GO:0071103) | 2.52315117 |
| 123 | regulation of chromatin binding (GO:0035561) | 2.51847634 |
| 124 | mannose metabolic process (GO:0006013) | 2.51637127 |
| 125 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.51484852 |
| 126 | translational elongation (GO:0006414) | 2.50824987 |
| 127 | peptidyl-arginine N-methylation (GO:0035246) | 2.49869814 |
| 128 | peptidyl-arginine methylation (GO:0018216) | 2.49869814 |
| 129 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.48735740 |
| 130 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.48130150 |
| 131 | modulation by virus of host morphology or physiology (GO:0019048) | 2.47896590 |
| 132 | corticosteroid receptor signaling pathway (GO:0031958) | 2.47646550 |
| 133 | chromatin assembly or disassembly (GO:0006333) | 2.46965985 |
| 134 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling | 2.46429244 |
| 135 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 2.46429244 |
| 136 | response to UV-C (GO:0010225) | 2.46379758 |
| 137 | morphogenesis of an endothelium (GO:0003159) | 2.45870267 |
| 138 | endothelial tube morphogenesis (GO:0061154) | 2.45870267 |
| 139 | protein-DNA complex disassembly (GO:0032986) | 2.44535639 |
| 140 | nucleosome disassembly (GO:0006337) | 2.44535639 |
| 141 | positive regulation of RNA splicing (GO:0033120) | 2.44251056 |
| 142 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.43962756 |
| 143 | negative regulation of viral release from host cell (GO:1902187) | 2.42929522 |
| 144 | adherens junction assembly (GO:0034333) | 2.41484300 |
| 145 | vesicle coating (GO:0006901) | 2.36358129 |
| 146 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.36157931 |
| 147 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.35849234 |
| 148 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.35648770 |
| 149 | regulation of nuclease activity (GO:0032069) | 2.35519977 |
| 150 | protein maturation by protein folding (GO:0022417) | 2.35345796 |
| 151 | amyloid precursor protein catabolic process (GO:0042987) | 2.35307191 |
| 152 | histone arginine methylation (GO:0034969) | 2.31026713 |
| 153 | hyaluronan catabolic process (GO:0030214) | 2.30411767 |
| 154 | response to peptidoglycan (GO:0032494) | 2.29555585 |
| 155 | regulation of cholesterol homeostasis (GO:2000188) | 2.27664730 |
| 156 | epithelial cell-cell adhesion (GO:0090136) | 2.27649383 |
| 157 | ER-nucleus signaling pathway (GO:0006984) | 2.27620384 |
| 158 | hemidesmosome assembly (GO:0031581) | 2.27471767 |
| 159 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.27325280 |
| 160 | activation of MAPKKK activity (GO:0000185) | 2.27093394 |
| 161 | cellular hyperosmotic response (GO:0071474) | 2.25989423 |
| 162 | NADH metabolic process (GO:0006734) | 2.24937307 |
| 163 | cellular response to interleukin-4 (GO:0071353) | 2.23801058 |
| 164 | detection of bacterium (GO:0016045) | 2.22440047 |
| 165 | trophectodermal cell differentiation (GO:0001829) | 2.22432783 |
| 166 | protein export from nucleus (GO:0006611) | 2.20180272 |
| 167 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.18840018 |
| 168 | response to muramyl dipeptide (GO:0032495) | 2.17047260 |
| 169 | cellular response to unfolded protein (GO:0034620) | 2.16515470 |
| 170 | detection of other organism (GO:0098543) | 2.16043303 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.19031624 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.30329798 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.78243999 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 3.49369834 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.20476587 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.15613087 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.57731463 |
| 8 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.42482740 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.35750511 |
| 10 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.13615097 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.09019001 |
| 12 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.06220811 |
| 13 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.99264690 |
| 14 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.88535129 |
| 15 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.79935180 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.79640625 |
| 17 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.79399356 |
| 18 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.78170558 |
| 19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.77016384 |
| 20 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.73875995 |
| 21 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.73092077 |
| 22 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.67479546 |
| 23 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.66623959 |
| 24 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.62219916 |
| 25 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.61423952 |
| 26 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.60445980 |
| 27 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.56985749 |
| 28 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.56145464 |
| 29 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.54629182 |
| 30 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.54249584 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 1.54082022 |
| 32 | UTX_26944678_Chip-Seq_JUKART_Human | 1.49705268 |
| 33 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.47802307 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.47399391 |
| 35 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.44947514 |
| 36 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.44837952 |
| 37 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.43342981 |
| 38 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.43119681 |
| 39 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37293601 |
| 40 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.36478128 |
| 41 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.35900319 |
| 42 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.35581037 |
| 43 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.35055071 |
| 44 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.34721484 |
| 45 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.34400178 |
| 46 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.33490539 |
| 47 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.32683199 |
| 48 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.32402393 |
| 49 | ATF3_27146783_Chip-Seq_COLON_Human | 1.31776007 |
| 50 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.31701953 |
| 51 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.29424664 |
| 52 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.29135677 |
| 53 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28970689 |
| 54 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.28922439 |
| 55 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.28891854 |
| 56 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.28154893 |
| 57 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.25469792 |
| 58 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.24298097 |
| 59 | P68_20966046_ChIP-Seq_HELA_Human | 1.23279874 |
| 60 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.22934046 |
| 61 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.21217271 |
| 62 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.20623559 |
| 63 | KDM2B_26808549_Chip-Seq_K562_Human | 1.20466762 |
| 64 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.19903344 |
| 65 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.19427427 |
| 66 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.18358479 |
| 67 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.18096676 |
| 68 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.17997482 |
| 69 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.17756615 |
| 70 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.17678621 |
| 71 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.17104229 |
| 72 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.16383663 |
| 73 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.15478571 |
| 74 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.14579587 |
| 75 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13372637 |
| 76 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.13278666 |
| 77 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12042588 |
| 78 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.11999825 |
| 79 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.11161077 |
| 80 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10606187 |
| 81 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10498545 |
| 82 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10269014 |
| 83 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.09312540 |
| 84 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08657499 |
| 85 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.08215357 |
| 86 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.08117142 |
| 87 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.06577404 |
| 88 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06559302 |
| 89 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.05823647 |
| 90 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.05577296 |
| 91 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.05407528 |
| 92 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05242583 |
| 93 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.05132584 |
| 94 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.05126532 |
| 95 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.04361702 |
| 96 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.04026925 |
| 97 | MYB_26560356_Chip-Seq_TH2_Human | 1.03864158 |
| 98 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03774450 |
| 99 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03025814 |
| 100 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.02929766 |
| 101 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02359840 |
| 102 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.02268048 |
| 103 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.02130981 |
| 104 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.01366698 |
| 105 | MAF_26560356_Chip-Seq_TH2_Human | 1.01285647 |
| 106 | MYB_26560356_Chip-Seq_TH1_Human | 1.01203140 |
| 107 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.01145506 |
| 108 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00691819 |
| 109 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.99880969 |
| 110 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.99741093 |
| 111 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.99385302 |
| 112 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.98975537 |
| 113 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98585402 |
| 114 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.98522206 |
| 115 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98104963 |
| 116 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.98050309 |
| 117 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.97505282 |
| 118 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.96228068 |
| 119 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.96118024 |
| 120 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.95532862 |
| 121 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.94822184 |
| 122 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.94111562 |
| 123 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91962433 |
| 124 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90362593 |
| 125 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.89501051 |
| 126 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.86550346 |
| 127 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.86416509 |
| 128 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.85376794 |
| 129 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85345698 |
| 130 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.84927089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 3.79497308 |
| 2 | MP0010352_gastrointestinal_tract_polyps | 3.39054206 |
| 3 | MP0005451_abnormal_body_composition | 3.14972358 |
| 4 | MP0005058_abnormal_lysosome_morphology | 2.95947162 |
| 5 | MP0005076_abnormal_cell_differentiation | 2.68739410 |
| 6 | MP0003300_gastrointestinal_ulcer | 2.49702023 |
| 7 | MP0008260_abnormal_autophagy | 2.45620328 |
| 8 | MP0010234_abnormal_vibrissa_follicle | 2.38692222 |
| 9 | MP0010307_abnormal_tumor_latency | 2.30572028 |
| 10 | MP0003111_abnormal_nucleus_morphology | 2.26371436 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.19337999 |
| 12 | MP0003436_decreased_susceptibility_to | 2.15075281 |
| 13 | MP0000537_abnormal_urethra_morphology | 2.14032209 |
| 14 | MP0004957_abnormal_blastocyst_morpholog | 2.13809057 |
| 15 | MP0006054_spinal_hemorrhage | 2.11328975 |
| 16 | MP0003077_abnormal_cell_cycle | 2.08755584 |
| 17 | MP0010094_abnormal_chromosome_stability | 2.06760138 |
| 18 | MP0003693_abnormal_embryo_hatching | 2.00704506 |
| 19 | MP0002396_abnormal_hematopoietic_system | 2.00003647 |
| 20 | MP0001730_embryonic_growth_arrest | 1.97331257 |
| 21 | MP0003566_abnormal_cell_adhesion | 1.92473577 |
| 22 | MP0004858_abnormal_nervous_system | 1.90748460 |
| 23 | MP0009278_abnormal_bone_marrow | 1.83825165 |
| 24 | MP0002796_impaired_skin_barrier | 1.80420864 |
| 25 | MP0004808_abnormal_hematopoietic_stem | 1.78919636 |
| 26 | MP0009053_abnormal_anal_canal | 1.78659122 |
| 27 | MP0004197_abnormal_fetal_growth/weight/ | 1.77333688 |
| 28 | MP0000350_abnormal_cell_proliferation | 1.77017216 |
| 29 | MP0005257_abnormal_intraocular_pressure | 1.73592223 |
| 30 | MP0002877_abnormal_melanocyte_morpholog | 1.72855536 |
| 31 | MP0001849_ear_inflammation | 1.65414315 |
| 32 | MP0003123_paternal_imprinting | 1.61818660 |
| 33 | MP0003283_abnormal_digestive_organ | 1.61270137 |
| 34 | MP0000733_abnormal_muscle_development | 1.58160310 |
| 35 | MP0003303_peritoneal_inflammation | 1.56795483 |
| 36 | MP0001672_abnormal_embryogenesis/_devel | 1.53373789 |
| 37 | MP0005380_embryogenesis_phenotype | 1.53373789 |
| 38 | MP0003984_embryonic_growth_retardation | 1.51358329 |
| 39 | MP0008007_abnormal_cellular_replicative | 1.51236473 |
| 40 | MP0005023_abnormal_wound_healing | 1.50641688 |
| 41 | MP0002088_abnormal_embryonic_growth/wei | 1.50093487 |
| 42 | MP0002086_abnormal_extraembryonic_tissu | 1.49091259 |
| 43 | MP0002084_abnormal_developmental_patter | 1.48757327 |
| 44 | MP0005501_abnormal_skin_physiology | 1.44841254 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.44570698 |
| 46 | MP0001697_abnormal_embryo_size | 1.44241971 |
| 47 | MP0008438_abnormal_cutaneous_collagen | 1.39583667 |
| 48 | MP0002080_prenatal_lethality | 1.38814058 |
| 49 | MP0002085_abnormal_embryonic_tissue | 1.36520252 |
| 50 | MP0009840_abnormal_foam_cell | 1.36228865 |
| 51 | MP0000490_abnormal_crypts_of | 1.33030160 |
| 52 | MP0010030_abnormal_orbit_morphology | 1.31983700 |
| 53 | MP0008961_abnormal_basal_metabolism | 1.26734682 |
| 54 | MP0001348_abnormal_lacrimal_gland | 1.26733605 |
| 55 | MP0001835_abnormal_antigen_presentation | 1.25689272 |
| 56 | MP0003567_abnormal_fetal_cardiomyocyte | 1.24382504 |
| 57 | MP0004185_abnormal_adipocyte_glucose | 1.24379498 |
| 58 | MP0003115_abnormal_respiratory_system | 1.21175944 |
| 59 | MP0003172_abnormal_lysosome_physiology | 1.20264009 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 1.16745844 |
| 61 | MP0001545_abnormal_hematopoietic_system | 1.16745844 |
| 62 | MP0005025_abnormal_response_to | 1.15868406 |
| 63 | MP0005409_darkened_coat_color | 1.13785180 |
| 64 | MP0001915_intracranial_hemorrhage | 1.13697725 |
| 65 | MP0008057_abnormal_DNA_replication | 1.13568421 |
| 66 | MP0004272_abnormal_basement_membrane | 1.13354112 |
| 67 | MP0000428_abnormal_craniofacial_morphol | 1.11382572 |
| 68 | MP0009672_abnormal_birth_weight | 1.11013442 |
| 69 | MP0000703_abnormal_thymus_morphology | 1.09974631 |
| 70 | MP0002419_abnormal_innate_immunity | 1.09200084 |
| 71 | MP0002019_abnormal_tumor_incidence | 1.09064625 |
| 72 | MP0001216_abnormal_epidermal_layer | 1.08742342 |
| 73 | MP0005387_immune_system_phenotype | 1.08414192 |
| 74 | MP0001790_abnormal_immune_system | 1.08414192 |
| 75 | MP0005000_abnormal_immune_tolerance | 1.08233168 |
| 76 | MP0000685_abnormal_immune_system | 1.07387797 |
| 77 | MP0003091_abnormal_cell_migration | 1.06581496 |
| 78 | MP0002060_abnormal_skin_morphology | 1.04856149 |
| 79 | MP0002092_abnormal_eye_morphology | 1.04524674 |
| 80 | MP0000678_abnormal_parathyroid_gland | 1.04016439 |
| 81 | MP0002166_altered_tumor_susceptibility | 1.03904836 |
| 82 | MP0001533_abnormal_skeleton_physiology | 1.03357406 |
| 83 | MP0003119_abnormal_digestive_system | 1.00775789 |
| 84 | MP0004264_abnormal_extraembryonic_tissu | 1.00684222 |
| 85 | MP0004233_abnormal_muscle_weight | 1.00594234 |
| 86 | MP0002452_abnormal_antigen_presenting | 0.95000220 |
| 87 | MP0001800_abnormal_humoral_immune | 0.94657721 |
| 88 | MP0000477_abnormal_intestine_morphology | 0.93592090 |
| 89 | MP0002398_abnormal_bone_marrow | 0.93157489 |
| 90 | MP0000858_altered_metastatic_potential | 0.93142030 |
| 91 | MP0001819_abnormal_immune_cell | 0.93076951 |
| 92 | MP0002420_abnormal_adaptive_immunity | 0.92742653 |
| 93 | MP0002925_abnormal_cardiovascular_devel | 0.92115458 |
| 94 | MP0005666_abnormal_adipose_tissue | 0.91993826 |
| 95 | MP0003329_amyloid_beta_deposits | 0.90793235 |
| 96 | MP0001293_anophthalmia | 0.90252620 |
| 97 | MP0009931_abnormal_skin_appearance | 0.89811934 |
| 98 | MP0000003_abnormal_adipose_tissue | 0.89663966 |
| 99 | MP0000313_abnormal_cell_death | 0.89626517 |
| 100 | MP0003221_abnormal_cardiomyocyte_apopto | 0.89626109 |
| 101 | MP0009703_decreased_birth_body | 0.88675283 |
| 102 | MP0003763_abnormal_thymus_physiology | 0.88334263 |
| 103 | MP0002722_abnormal_immune_system | 0.87787964 |
| 104 | MP0002723_abnormal_immune_serum | 0.87675634 |
| 105 | MP0002089_abnormal_postnatal_growth/wei | 0.87093917 |
| 106 | MP0008932_abnormal_embryonic_tissue | 0.87080317 |
| 107 | MP0010630_abnormal_cardiac_muscle | 0.86305654 |
| 108 | MP0009333_abnormal_splenocyte_physiolog | 0.85550607 |
| 109 | MP0004947_skin_inflammation | 0.85310386 |
| 110 | MP0003279_aneurysm | 0.84261864 |
| 111 | MP0008004_abnormal_stomach_pH | 0.83952211 |
| 112 | MP0005623_abnormal_meninges_morphology | 0.83610331 |
| 113 | MP0002111_abnormal_tail_morphology | 0.82893357 |
| 114 | MP0000716_abnormal_immune_system | 0.82637590 |
| 115 | MP0002697_abnormal_eye_size | 0.82117116 |
| 116 | MP0003890_abnormal_embryonic-extraembry | 0.82050095 |
| 117 | MP0004782_abnormal_surfactant_physiolog | 0.81001584 |
| 118 | MP0003828_pulmonary_edema | 0.80536334 |
| 119 | MP0000465_gastrointestinal_hemorrhage | 0.80498182 |
| 120 | MP0002998_abnormal_bone_remodeling | 0.80290439 |
| 121 | MP0008770_decreased_survivor_rate | 0.79014415 |
| 122 | MP0000598_abnormal_liver_morphology | 0.78602113 |
| 123 | MP0003075_altered_response_to | 0.78400655 |
| 124 | MP0000689_abnormal_spleen_morphology | 0.78023405 |
| 125 | MP0002405_respiratory_system_inflammati | 0.77938762 |
| 126 | MP0001851_eye_inflammation | 0.76290082 |
| 127 | MP0001853_heart_inflammation | 0.75966562 |
| 128 | MP0005621_abnormal_cell_physiology | 0.75152016 |
| 129 | MP0003121_genomic_imprinting | 0.74994471 |
| 130 | MP0000266_abnormal_heart_morphology | 0.74419768 |
| 131 | MP0005375_adipose_tissue_phenotype | 0.73588187 |
| 132 | MP0002932_abnormal_joint_morphology | 0.72194004 |
| 133 | MP0002234_abnormal_pharynx_morphology | 0.71407410 |
| 134 | MP0005275_abnormal_skin_tensile | 0.70676843 |
| 135 | MP0003453_abnormal_keratinocyte_physiol | 0.70078049 |
| 136 | MP0000534_abnormal_ureter_morphology | 0.70063206 |
| 137 | MP0001958_emphysema | 0.69437865 |
| 138 | MP0003935_abnormal_craniofacial_develop | 0.69206585 |
| 139 | MP0000609_abnormal_liver_physiology | 0.68828901 |
| 140 | MP0002429_abnormal_blood_cell | 0.68802863 |
| 141 | MP0010155_abnormal_intestine_physiology | 0.67874989 |
| 142 | MP0005384_cellular_phenotype | 0.65284095 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperacusis (HP:0010780) | 3.47316737 |
| 2 | Protrusio acetabuli (HP:0003179) | 3.28067875 |
| 3 | Ependymoma (HP:0002888) | 3.16764113 |
| 4 | Cerebral aneurysm (HP:0004944) | 3.13417162 |
| 5 | Short 4th metacarpal (HP:0010044) | 3.12461542 |
| 6 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 3.12461542 |
| 7 | Vertebral compression fractures (HP:0002953) | 2.97562972 |
| 8 | Increased density of long bones (HP:0006392) | 2.75057963 |
| 9 | Shallow orbits (HP:0000586) | 2.70684605 |
| 10 | Abnormality of the 4th metacarpal (HP:0010012) | 2.62766165 |
| 11 | Renal duplication (HP:0000075) | 2.61309561 |
| 12 | Ankle contracture (HP:0006466) | 2.60324055 |
| 13 | Cellulitis (HP:0100658) | 2.56199351 |
| 14 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.56043103 |
| 15 | Spastic diplegia (HP:0001264) | 2.52672389 |
| 16 | Abnormality of the astrocytes (HP:0100707) | 2.51908697 |
| 17 | Astrocytoma (HP:0009592) | 2.51908697 |
| 18 | Ulnar bowing (HP:0003031) | 2.50447771 |
| 19 | Eczematoid dermatitis (HP:0000976) | 2.49576428 |
| 20 | Increased nuchal translucency (HP:0010880) | 2.47991931 |
| 21 | Elfin facies (HP:0004428) | 2.44110394 |
| 22 | Selective tooth agenesis (HP:0001592) | 2.40945752 |
| 23 | Bowel diverticulosis (HP:0005222) | 2.40722253 |
| 24 | Subacute progressive viral hepatitis (HP:0006572) | 2.39060766 |
| 25 | Aortic aneurysm (HP:0004942) | 2.38443955 |
| 26 | Renovascular hypertension (HP:0100817) | 2.33520151 |
| 27 | Deviation of the thumb (HP:0009603) | 2.31843395 |
| 28 | Pseudobulbar signs (HP:0002200) | 2.31623404 |
| 29 | Long palpebral fissure (HP:0000637) | 2.31307552 |
| 30 | Flat acetabular roof (HP:0003180) | 2.30775714 |
| 31 | Distal lower limb amyotrophy (HP:0008944) | 2.30265277 |
| 32 | Medulloblastoma (HP:0002885) | 2.26801642 |
| 33 | Basal cell carcinoma (HP:0002671) | 2.26727495 |
| 34 | Hand muscle atrophy (HP:0009130) | 2.25094347 |
| 35 | Proximal placement of thumb (HP:0009623) | 2.24852297 |
| 36 | Cholecystitis (HP:0001082) | 2.24518199 |
| 37 | Abnormal gallbladder physiology (HP:0012438) | 2.24518199 |
| 38 | Increased connective tissue (HP:0009025) | 2.23477951 |
| 39 | Hemorrhage of the eye (HP:0011885) | 2.23437473 |
| 40 | Broad face (HP:0000283) | 2.22210815 |
| 41 | Colon cancer (HP:0003003) | 2.22020025 |
| 42 | Mitral valve prolapse (HP:0001634) | 2.21635249 |
| 43 | Abnormality of the thoracic spine (HP:0100711) | 2.20480990 |
| 44 | Dilatation of the ascending aorta (HP:0005111) | 2.19008923 |
| 45 | Rectal prolapse (HP:0002035) | 2.17612045 |
| 46 | Upper limb amyotrophy (HP:0009129) | 2.16987383 |
| 47 | Distal upper limb amyotrophy (HP:0007149) | 2.16987383 |
| 48 | Cutaneous melanoma (HP:0012056) | 2.15066940 |
| 49 | Disproportionate tall stature (HP:0001519) | 2.12987078 |
| 50 | Lymphangioma (HP:0100764) | 2.12332524 |
| 51 | Thoracic kyphosis (HP:0002942) | 2.09112080 |
| 52 | Increased IgE level (HP:0003212) | 2.08953457 |
| 53 | Abnormality of oral frenula (HP:0000190) | 2.08476665 |
| 54 | Enlarged penis (HP:0000040) | 2.08392894 |
| 55 | Aneurysm (HP:0002617) | 2.07582649 |
| 56 | High pitched voice (HP:0001620) | 2.07306492 |
| 57 | Gastrointestinal carcinoma (HP:0002672) | 2.06830856 |
| 58 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.06830856 |
| 59 | Short nail (HP:0001799) | 2.06057476 |
| 60 | Insomnia (HP:0100785) | 2.02489154 |
| 61 | Pointed chin (HP:0000307) | 2.02019799 |
| 62 | Distal lower limb muscle weakness (HP:0009053) | 2.01702275 |
| 63 | Genu recurvatum (HP:0002816) | 2.01340719 |
| 64 | Fibroma (HP:0010614) | 2.01076163 |
| 65 | Asymmetry of the thorax (HP:0001555) | 2.00990814 |
| 66 | Radial bowing (HP:0002986) | 2.00672325 |
| 67 | Adenoma sebaceum (HP:0009720) | 2.00240137 |
| 68 | Angiofibromas (HP:0010615) | 2.00240137 |
| 69 | Overriding aorta (HP:0002623) | 1.99539854 |
| 70 | Ankyloglossia (HP:0010296) | 1.99445845 |
| 71 | Hypertensive crisis (HP:0100735) | 1.99444375 |
| 72 | Fibrous tissue neoplasm (HP:0012316) | 1.98865891 |
| 73 | Bladder diverticulum (HP:0000015) | 1.97885577 |
| 74 | Abnormality of macrophages (HP:0004311) | 1.96913658 |
| 75 | Bicuspid aortic valve (HP:0001647) | 1.96472928 |
| 76 | Reticulocytosis (HP:0001923) | 1.95555956 |
| 77 | Hallux valgus (HP:0001822) | 1.94845247 |
| 78 | Glioma (HP:0009733) | 1.94155155 |
| 79 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.93933597 |
| 80 | Abnormality of the calcaneus (HP:0008364) | 1.93322062 |
| 81 | Biliary tract neoplasm (HP:0100574) | 1.92747689 |
| 82 | Deviation of the hallux (HP:0010051) | 1.92220602 |
| 83 | Polygenic inheritance (HP:0010982) | 1.89610697 |
| 84 | Hyperparathyroidism (HP:0000843) | 1.86860900 |
| 85 | Thrombocytosis (HP:0001894) | 1.86146100 |
| 86 | Cervical subluxation (HP:0003308) | 1.84664546 |
| 87 | Bowed forearm bones (HP:0003956) | 1.84563422 |
| 88 | Bowing of the arm (HP:0006488) | 1.84563422 |
| 89 | Trismus (HP:0000211) | 1.84028377 |
| 90 | Abnormality of the peritoneum (HP:0002585) | 1.83849632 |
| 91 | Progressive muscle weakness (HP:0003323) | 1.83725689 |
| 92 | Loss of speech (HP:0002371) | 1.83491614 |
| 93 | Colitis (HP:0002583) | 1.82978234 |
| 94 | Heterotopia (HP:0002282) | 1.82238706 |
| 95 | Neoplasm of striated muscle (HP:0009728) | 1.81402217 |
| 96 | Back pain (HP:0003418) | 1.80914755 |
| 97 | Progressive external ophthalmoplegia (HP:0000590) | 1.80535013 |
| 98 | Skin tags (HP:0010609) | 1.80441700 |
| 99 | Gastrointestinal stroma tumor (HP:0100723) | 1.80201960 |
| 100 | Abnormality of the fingertips (HP:0001211) | 1.79715723 |
| 101 | Long toe (HP:0010511) | 1.79353006 |
| 102 | Broad palm (HP:0001169) | 1.79339060 |
| 103 | Ragged-red muscle fibers (HP:0003200) | 1.79103651 |
| 104 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.77867510 |
| 105 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.77867510 |
| 106 | Abnormality of glycolipid metabolism (HP:0010969) | 1.77867510 |
| 107 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.76944544 |
| 108 | Interstitial pulmonary disease (HP:0006530) | 1.76891964 |
| 109 | Dysostosis multiplex (HP:0000943) | 1.75942457 |
| 110 | Thin bony cortex (HP:0002753) | 1.75314597 |
| 111 | Increased cerebral lipofuscin (HP:0011813) | 1.74847397 |
| 112 | Gastrointestinal inflammation (HP:0004386) | 1.74350497 |
| 113 | Rhabdomyosarcoma (HP:0002859) | 1.74098866 |
| 114 | Multiple enchondromatosis (HP:0005701) | 1.73917643 |
| 115 | Intestinal polyp (HP:0005266) | 1.73539852 |
| 116 | Spinal cord lesions (HP:0100561) | 1.73386564 |
| 117 | Syringomyelia (HP:0003396) | 1.73386564 |
| 118 | Increased variability in muscle fiber diameter (HP:0003557) | 1.73322737 |
| 119 | Macroorchidism (HP:0000053) | 1.72282399 |
| 120 | Deep venous thrombosis (HP:0002625) | 1.72274341 |
| 121 | Purpura (HP:0000979) | 1.71568988 |
| 122 | Orthostatic hypotension (HP:0001278) | 1.70903529 |
| 123 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.70491076 |
| 124 | Blue sclerae (HP:0000592) | 1.69817698 |
| 125 | Natal tooth (HP:0000695) | 1.68232739 |
| 126 | Osteolytic defects of the hand bones (HP:0009699) | 1.68097343 |
| 127 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.68097343 |
| 128 | Fragile skin (HP:0001030) | 1.67841047 |
| 129 | Abnormal platelet volume (HP:0011876) | 1.67516896 |
| 130 | Broad thumb (HP:0011304) | 1.66710971 |
| 131 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.65541678 |
| 132 | Recurrent abscess formation (HP:0002722) | 1.65362773 |
| 133 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.64690389 |
| 134 | Persistence of primary teeth (HP:0006335) | 1.64213210 |
| 135 | Intestinal polyposis (HP:0200008) | 1.64168241 |
| 136 | Premature rupture of membranes (HP:0001788) | 1.63898528 |
| 137 | Long eyelashes (HP:0000527) | 1.63640728 |
| 138 | Achilles tendon contracture (HP:0001771) | 1.63516597 |
| 139 | Trigonocephaly (HP:0000243) | 1.63307581 |
| 140 | Fatigue (HP:0012378) | 1.62544208 |
| 141 | Spinal rigidity (HP:0003306) | 1.61878751 |
| 142 | Abnormality of the lower motor neuron (HP:0002366) | 1.61672008 |
| 143 | Biconcave vertebral bodies (HP:0004586) | 1.61526399 |
| 144 | Hematochezia (HP:0002573) | 1.61410477 |
| 145 | Severe short stature (HP:0003510) | 1.60896530 |
| 146 | Advanced eruption of teeth (HP:0006288) | 1.60255074 |
| 147 | Recurrent viral infections (HP:0004429) | 1.60148270 |
| 148 | Missing ribs (HP:0000921) | 1.60040062 |
| 149 | Papilloma (HP:0012740) | 1.59597901 |
| 150 | Verrucae (HP:0200043) | 1.59597901 |
| 151 | Cutis marmorata (HP:0000965) | 1.59513902 |
| 152 | Ridged nail (HP:0001807) | 1.59361604 |
| 153 | Viral hepatitis (HP:0006562) | 1.59063283 |
| 154 | Bone pain (HP:0002653) | 1.59036558 |
| 155 | Abnormality of the Achilles tendon (HP:0005109) | 1.59022149 |
| 156 | Prominent nose (HP:0000448) | 1.58884567 |
| 157 | Emphysema (HP:0002097) | 1.58725737 |
| 158 | Sandal gap (HP:0001852) | 1.57950230 |
| 159 | Flat cornea (HP:0007720) | 1.57456687 |
| 160 | Mitral regurgitation (HP:0001653) | 1.57244541 |
| 161 | Striae distensae (HP:0001065) | 1.57203438 |
| 162 | Abnormal ossification of hand bones (HP:0005921) | 1.56604362 |
| 163 | Upper motor neuron abnormality (HP:0002127) | 1.56472670 |
| 164 | Metaphyseal cupping (HP:0003021) | 1.56219143 |
| 165 | Chronic obstructive pulmonary disease (HP:0006510) | 1.55724186 |
| 166 | Obstructive lung disease (HP:0006536) | 1.55724186 |
| 167 | Aortic dissection (HP:0002647) | 1.55575192 |
| 168 | Uterine neoplasm (HP:0010784) | 1.55537768 |
| 169 | Micronodular cirrhosis (HP:0001413) | 1.55494278 |
| 170 | Neoplasm of the oral cavity (HP:0100649) | 1.54520340 |
| 171 | Patellar dislocation (HP:0002999) | 1.54161575 |
| 172 | Polycythemia (HP:0001901) | 1.53944460 |
| 173 | Neuronal loss in central nervous system (HP:0002529) | 1.51739189 |
| 174 | Myocardial infarction (HP:0001658) | 1.51123304 |
| 175 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.50297270 |
| 176 | Gingivitis (HP:0000230) | 1.49783880 |
| 177 | Atrophic scars (HP:0001075) | 1.49627867 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EEF2K | 4.69846912 |
| 2 | TRIB3 | 4.47984167 |
| 3 | PKN2 | 4.01904954 |
| 4 | SMG1 | 3.86106757 |
| 5 | MAP3K10 | 3.64626635 |
| 6 | PRPF4B | 3.25961068 |
| 7 | CDK12 | 2.51066448 |
| 8 | IRAK3 | 2.32896646 |
| 9 | SCYL2 | 2.18409572 |
| 10 | NEK2 | 2.09193775 |
| 11 | CDC7 | 2.05913881 |
| 12 | ERN1 | 2.01177340 |
| 13 | NME2 | 2.00905475 |
| 14 | TTN | 1.96038035 |
| 15 | LRRK2 | 1.93913272 |
| 16 | PTK6 | 1.85822646 |
| 17 | NEK1 | 1.85506853 |
| 18 | RPS6KB2 | 1.82686520 |
| 19 | PASK | 1.75201639 |
| 20 | PAK4 | 1.63481215 |
| 21 | ARAF | 1.62265181 |
| 22 | PDGFRA | 1.61967199 |
| 23 | SIK1 | 1.58139901 |
| 24 | FLT3 | 1.55932923 |
| 25 | TAOK2 | 1.53392514 |
| 26 | STK10 | 1.53123787 |
| 27 | ALK | 1.48359325 |
| 28 | MAP3K13 | 1.47856822 |
| 29 | RIPK1 | 1.47513881 |
| 30 | CDK4 | 1.44848522 |
| 31 | MAP4K1 | 1.44564394 |
| 32 | CDK6 | 1.39530563 |
| 33 | MAP3K8 | 1.33087448 |
| 34 | TGFBR1 | 1.29220900 |
| 35 | MTOR | 1.24393812 |
| 36 | FGFR4 | 1.16916558 |
| 37 | PIM2 | 1.15875600 |
| 38 | RIPK4 | 1.13689098 |
| 39 | MST1R | 1.13405004 |
| 40 | RPS6KA4 | 1.13144052 |
| 41 | WEE1 | 1.12391580 |
| 42 | LATS1 | 1.12306058 |
| 43 | ICK | 1.11838370 |
| 44 | GRK6 | 1.09781056 |
| 45 | MAP3K14 | 1.06819641 |
| 46 | BMX | 1.06047142 |
| 47 | TESK2 | 1.05718488 |
| 48 | PAK2 | 1.03491264 |
| 49 | MAP3K3 | 0.99903083 |
| 50 | MAP2K3 | 0.98296840 |
| 51 | TSSK6 | 0.97117367 |
| 52 | CAMK1D | 0.94117805 |
| 53 | TBK1 | 0.93554595 |
| 54 | MAP3K1 | 0.90221186 |
| 55 | MAPKAPK3 | 0.89436719 |
| 56 | TTK | 0.88950640 |
| 57 | SIK3 | 0.86522622 |
| 58 | CDC42BPA | 0.84213096 |
| 59 | FGFR1 | 0.83466535 |
| 60 | ATR | 0.82165704 |
| 61 | IRAK4 | 0.81646604 |
| 62 | CDK7 | 0.81089026 |
| 63 | BUB1 | 0.80212229 |
| 64 | MAP3K9 | 0.78429610 |
| 65 | BRAF | 0.77725914 |
| 66 | EPHA2 | 0.76922822 |
| 67 | LMTK2 | 0.73307979 |
| 68 | STK4 | 0.72409123 |
| 69 | CHEK1 | 0.71828146 |
| 70 | AURKB | 0.71777113 |
| 71 | TAOK1 | 0.71694539 |
| 72 | FGFR3 | 0.71299394 |
| 73 | STK3 | 0.71067801 |
| 74 | ILK | 0.70704431 |
| 75 | PRKD2 | 0.70485743 |
| 76 | RET | 0.69123518 |
| 77 | MARK2 | 0.67412636 |
| 78 | PDPK1 | 0.67040277 |
| 79 | TESK1 | 0.66846114 |
| 80 | ZAP70 | 0.66185310 |
| 81 | JAK3 | 0.66062480 |
| 82 | LATS2 | 0.65599550 |
| 83 | KSR2 | 0.64380276 |
| 84 | PTK2 | 0.64115237 |
| 85 | KSR1 | 0.62270011 |
| 86 | BRD4 | 0.61868629 |
| 87 | BTK | 0.60880921 |
| 88 | PDGFRB | 0.60478122 |
| 89 | CSK | 0.60447758 |
| 90 | RPS6KA2 | 0.59942042 |
| 91 | PRKD3 | 0.59553126 |
| 92 | CSF1R | 0.58516941 |
| 93 | NTRK1 | 0.58272726 |
| 94 | PIM1 | 0.57304780 |
| 95 | DDR2 | 0.56430214 |
| 96 | MOS | 0.56024181 |
| 97 | TYRO3 | 0.54624258 |
| 98 | MET | 0.53917414 |
| 99 | CAMK1G | 0.53702913 |
| 100 | MAP3K7 | 0.53695958 |
| 101 | IRAK2 | 0.52602535 |
| 102 | TGFBR2 | 0.52364462 |
| 103 | CDK2 | 0.51039414 |
| 104 | MAP3K6 | 0.51032766 |
| 105 | CDK9 | 0.50947377 |
| 106 | DYRK1B | 0.50345789 |
| 107 | SIK2 | 0.50301291 |
| 108 | RAF1 | 0.49523322 |
| 109 | CDK8 | 0.49037624 |
| 110 | DYRK3 | 0.48985464 |
| 111 | PLK1 | 0.48630246 |
| 112 | HIPK2 | 0.48318712 |
| 113 | MAP2K2 | 0.46961646 |
| 114 | RPS6KL1 | 0.46916953 |
| 115 | RPS6KC1 | 0.46916953 |
| 116 | MAPK11 | 0.46581292 |
| 117 | AKT2 | 0.46486851 |
| 118 | CLK1 | 0.45735359 |
| 119 | FGR | 0.44434086 |
| 120 | NEK9 | 0.42074107 |
| 121 | KDR | 0.41691619 |
| 122 | ITK | 0.41510116 |
| 123 | TYK2 | 0.41244045 |
| 124 | AURKA | 0.40380762 |
| 125 | EPHB2 | 0.39320936 |
| 126 | ERBB2 | 0.38901401 |
| 127 | FGFR2 | 0.38606617 |
| 128 | VRK2 | 0.38435468 |
| 129 | RPS6KA1 | 0.37406949 |
| 130 | JAK2 | 0.37235542 |
| 131 | ATM | 0.36854571 |
| 132 | MAPKAPK2 | 0.35623245 |
| 133 | HCK | 0.35568825 |
| 134 | ACVR1B | 0.34830276 |
| 135 | DMPK | 0.34268078 |
| 136 | EPHB1 | 0.33532457 |
| 137 | PAK1 | 0.33495681 |
| 138 | BRSK2 | 0.33058504 |
| 139 | CHEK2 | 0.32864754 |
| 140 | PDK1 | 0.32004218 |
| 141 | CDK11A | 0.31905376 |
| 142 | BRSK1 | 0.31848110 |
| 143 | PRKG2 | 0.31847053 |
| 144 | LIMK1 | 0.31738099 |
| 145 | CDK14 | 0.31489671 |
| 146 | MAP3K11 | 0.31233439 |
| 147 | BCKDK | 0.30983454 |
| 148 | BLK | 0.30817528 |
| 149 | CHUK | 0.30784321 |
| 150 | CDK15 | 0.29579588 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 2.93056039 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.58321837 |
| 3 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.42133153 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.41395042 |
| 5 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 2.06148896 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 2.01877880 |
| 7 | Cell cycle_Homo sapiens_hsa04110 | 1.84123627 |
| 8 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.80780496 |
| 9 | RNA transport_Homo sapiens_hsa03013 | 1.75178030 |
| 10 | Spliceosome_Homo sapiens_hsa03040 | 1.71895625 |
| 11 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.54905284 |
| 12 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.53912419 |
| 13 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.52277817 |
| 14 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.50795873 |
| 15 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.50417744 |
| 16 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.49856724 |
| 17 | Base excision repair_Homo sapiens_hsa03410 | 1.49434164 |
| 18 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.47313121 |
| 19 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.44975172 |
| 20 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.44723911 |
| 21 | Lysine degradation_Homo sapiens_hsa00310 | 1.44127771 |
| 22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.43670514 |
| 23 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.41876896 |
| 24 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.41300146 |
| 25 | Bladder cancer_Homo sapiens_hsa05219 | 1.39597689 |
| 26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.37626789 |
| 27 | Galactose metabolism_Homo sapiens_hsa00052 | 1.34854773 |
| 28 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.33748131 |
| 29 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.30737736 |
| 30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.25970658 |
| 31 | HTLV-I infection_Homo sapiens_hsa05166 | 1.24757703 |
| 32 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.24518697 |
| 33 | Colorectal cancer_Homo sapiens_hsa05210 | 1.24329812 |
| 34 | Leishmaniasis_Homo sapiens_hsa05140 | 1.22549036 |
| 35 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.22251193 |
| 36 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.21703000 |
| 37 | Hepatitis C_Homo sapiens_hsa05160 | 1.21056995 |
| 38 | Prion diseases_Homo sapiens_hsa05020 | 1.20035720 |
| 39 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.19663641 |
| 40 | Influenza A_Homo sapiens_hsa05164 | 1.19206386 |
| 41 | Adherens junction_Homo sapiens_hsa04520 | 1.15646511 |
| 42 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.14385594 |
| 43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.14191914 |
| 44 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.11949390 |
| 45 | Thyroid cancer_Homo sapiens_hsa05216 | 1.11786340 |
| 46 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.10599595 |
| 47 | Endometrial cancer_Homo sapiens_hsa05213 | 1.10445114 |
| 48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.09909904 |
| 49 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.05377997 |
| 50 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.02148367 |
| 51 | Focal adhesion_Homo sapiens_hsa04510 | 1.01957752 |
| 52 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.01534138 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 1.01024538 |
| 54 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.00396613 |
| 55 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.00023399 |
| 56 | Carbon metabolism_Homo sapiens_hsa01200 | 0.98439309 |
| 57 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.97605149 |
| 58 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.95989806 |
| 59 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.95638918 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 0.95538678 |
| 61 | Insulin resistance_Homo sapiens_hsa04931 | 0.95150106 |
| 62 | Lysosome_Homo sapiens_hsa04142 | 0.94796594 |
| 63 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.92208176 |
| 64 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.92073689 |
| 65 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.91177466 |
| 66 | Hepatitis B_Homo sapiens_hsa05161 | 0.90667013 |
| 67 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.90105134 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.89043940 |
| 69 | Measles_Homo sapiens_hsa05162 | 0.88918131 |
| 70 | Glioma_Homo sapiens_hsa05214 | 0.88598087 |
| 71 | Apoptosis_Homo sapiens_hsa04210 | 0.88596472 |
| 72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.87294939 |
| 73 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.87169607 |
| 74 | Tuberculosis_Homo sapiens_hsa05152 | 0.85892403 |
| 75 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85143196 |
| 76 | Endocytosis_Homo sapiens_hsa04144 | 0.84426073 |
| 77 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.84424103 |
| 78 | Shigellosis_Homo sapiens_hsa05131 | 0.81531269 |
| 79 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.81479226 |
| 80 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.81421526 |
| 81 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.79710256 |
| 82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.78985943 |
| 83 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.78610951 |
| 84 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.77864382 |
| 85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.77320144 |
| 86 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.76307877 |
| 87 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.73305361 |
| 88 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.72475313 |
| 89 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.71283221 |
| 90 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.69024101 |
| 91 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.68031890 |
| 92 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.68008441 |
| 93 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.67542882 |
| 94 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.67439352 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67289462 |
| 96 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.66810481 |
| 97 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.66183900 |
| 98 | Legionellosis_Homo sapiens_hsa05134 | 0.66134768 |
| 99 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.65916049 |
| 100 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65132998 |
| 101 | Sulfur relay system_Homo sapiens_hsa04122 | 0.65108737 |
| 102 | Pathways in cancer_Homo sapiens_hsa05200 | 0.64552554 |
| 103 | Prostate cancer_Homo sapiens_hsa05215 | 0.61997330 |
| 104 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.61534754 |
| 105 | Ribosome_Homo sapiens_hsa03010 | 0.61395491 |
| 106 | Alcoholism_Homo sapiens_hsa05034 | 0.59626060 |
| 107 | Platelet activation_Homo sapiens_hsa04611 | 0.59194865 |
| 108 | Phagosome_Homo sapiens_hsa04145 | 0.58974128 |
| 109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58438059 |
| 110 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.58171229 |
| 111 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.58062459 |
| 112 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57864929 |
| 113 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.57857747 |
| 114 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.57447044 |
| 115 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.55693978 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55416957 |
| 117 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.55110941 |
| 118 | Amoebiasis_Homo sapiens_hsa05146 | 0.55045118 |
| 119 | Pertussis_Homo sapiens_hsa05133 | 0.55043718 |
| 120 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.54872449 |
| 121 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.54775823 |
| 122 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.54538187 |
| 123 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.53518682 |
| 124 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.53009374 |
| 125 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52690494 |
| 126 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.51513269 |
| 127 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.51473162 |
| 128 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.51450191 |
| 129 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51413472 |
| 130 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51254575 |
| 131 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.51247135 |
| 132 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50926963 |
| 133 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.50260777 |

